Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00331071
Status:
COMPLETED
Last Update Posted:
2016-07-19
First Post:
2006-05-26
Brief Title:
Postmarketing Study of ORTHO EVRA Norelgestromin and Ethinyl Estradiol Contraceptive Patch in Relation to Venous Thromboembolism Blood Clots Stroke and Heart Attacks
Sponsor:
Organization:
Johnson Johnson Pharmaceutical Research Development LLC
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
334
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Control |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 2162 |
Who Masked List: